Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Skyepharma PLC

+ Add to Watchlist

SKYEY:US

4.7300 USD 0.1600 3.50%

As of 20:10:01 ET on 04/24/2015.

Snapshot for Skyepharma PLC (SKYEY)

Open: 4.7300 Day's Range: 4.7300 - 4.7300 Volume: 1,000
Previous Close: 4.5700 52wk Range: 3.8100 - 5.9700 1-Yr Rtn: +22.86%

Stock Chart for SKYEY

No chart data available.
  • SKYEY:US 4.7300
  • 1D
  • 1M
  • 1Y
4.5700
Interactive SKYEY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SKYEY

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 13.9759
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (12/2015) 0.2220
Est. PEG Ratio -
Market Cap (M USD) 495.76
Shares Outstanding (M) 104.81
30 Day Average Volume 347
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 1.7534
Dividend Ex-Date 11/02/2005
5 Year Dividend Growth -
Next Earnings Announcement 08/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SKYEY

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for SKYEY

SkyePharma plc operates a group of companies that research, develop, manufacture and market prescription pharmaceutical products. The Group's products are available in topical, oral, injectable and inhalation form.

Peter William GrantCEO/Exec DirAndrew DerodraCFO/Exec Dir
John MurphySecretary/General Counsel
More Company Profile & Key Executives for SKYEY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil